188 related articles for article (PubMed ID: 19210288)
1. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease.
Wiggelinkhuizen M; Tilanus ME; Bollen CW; Houwen RH
Aliment Pharmacol Ther; 2009 May; 29(9):947-58. PubMed ID: 19210288
[TBL] [Abstract][Full Text] [Related]
2. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
[TBL] [Abstract][Full Text] [Related]
4. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
6. [Wilson Disease].
Rev Prat; 2014 Apr; 64(4):564. PubMed ID: 24855798
[No Abstract] [Full Text] [Related]
7. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
Brewer GJ; Askari F; Lorincz MT; Carlson M; Schilsky M; Kluin KJ; Hedera P; Moretti P; Fink JK; Tankanow R; Dick RB; Sitterly J
Arch Neurol; 2006 Apr; 63(4):521-7. PubMed ID: 16606763
[TBL] [Abstract][Full Text] [Related]
8. Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.
Seessle J; Gotthardt DN; Schäfer M; Gohdes A; Pfeiffenberger J; Ferenci P; Stremmel W; Weiss KH
J Inherit Metab Dis; 2016 Jan; 39(1):125-30. PubMed ID: 26067812
[TBL] [Abstract][Full Text] [Related]
9. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
Schilsky M
Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
[No Abstract] [Full Text] [Related]
10. Response to different therapeutic approaches in Wilson disease. A long-term follow up study.
Rodríguez B; Burguera J; Berenguer M
Ann Hepatol; 2012; 11(6):907-14. PubMed ID: 23109455
[TBL] [Abstract][Full Text] [Related]
11. Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study.
Tai CS; Wu JF; Chen HL; Hsu HY; Chang MH; Ni YH
J Formos Med Assoc; 2018 May; 117(5):421-426. PubMed ID: 28578978
[TBL] [Abstract][Full Text] [Related]
12. Wilson disease: what is still unclear in pediatric patients?
Ranucci G; Socha P; Iorio R
Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):268-72. PubMed ID: 24745882
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
Selimoglu MA; Ertekin V; Doneray H; Yildirim M
J Clin Gastroenterol; 2008 Feb; 42(2):194-8. PubMed ID: 18209591
[TBL] [Abstract][Full Text] [Related]
14. Wilson disease.
El-Youssef M
Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
[TBL] [Abstract][Full Text] [Related]
15. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
[TBL] [Abstract][Full Text] [Related]
16. Wilson disease--a practical approach to diagnosis, treatment and follow-up.
Medici V; Rossaro L; Sturniolo GC
Dig Liver Dis; 2007 Jul; 39(7):601-9. PubMed ID: 17382611
[TBL] [Abstract][Full Text] [Related]
17. 'Face of the giant panda' sign in Wilson disease.
Thapa R; Ghosh A
Pediatr Radiol; 2008 Dec; 38(12):1355. PubMed ID: 18839167
[No Abstract] [Full Text] [Related]
18. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
19. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]